PR NEWSWIRE

Previous Stories

Seeing Machines to showcase world-leading AI-powered interior sensing technology at Automotive World 2024 in Tokyo

Jan 23 2024 - PR NewsWire

– Automotive World is one of the world’s leading innovation focused exhibitions for advanced automotive technologies for OEMs and Tier…


Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)

Jan 22 2024 - PR NewsWire

MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the…


PEPPERSTONE ANNOUNCES REGIONAL PARTNERSHIP OF THE AFC ASIAN CUP 2024

Jan 22 2024 - PR NewsWire

MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ — Pepperstone, a globally recognised Forex (FX) and Contracts for Difference (CFD) broker, announces…


Manhattan Debuts the First and Only Fulfillment Experience Insights Dashboard for Retail

Jan 22 2024 - PR NewsWire

Realtime capability enables retailers to compare key fulfillment metrics against their peers MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ – Manhattan Associates (NASDAQ:…


FP Markets Partners with Industry-Leading Platform Provider TradingView

Jan 20 2024 - PR NewsWire

FP Markets’ customers around the world can now gain access to TradingView’s advanced charts and analysis, powerful trading tools and…


Vantage Australia releases the latest hard-hitting episode of The Vantage View, discussing the circular economy

Jan 19 2024 - PR NewsWire

The video series is a collaborative effort between Vantage Markets and Bloomberg Media Studios  SYDNEY, Jan. 19, 2024 /PRNewswire/ —…


Xailient AI Powers Award-Winning Abode Edge Camera at CES 2024

Jan 18 2024 - PR NewsWire

SYDNEY, Jan. 18, 2024 /PRNewswire/ — Xalient customer Abode, a leading provider of DIY smart home security solutions, has been…


FDA CLEARANCE OF AMPLIA’S IND FOR PANCREATIC CANCER TRIAL IN US

Jan 18 2024 - PR NewsWire

HIGHLIGHTS The US FDA has cleared Amplia’s Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the USA…


SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

Jan 17 2024 - PR NewsWire

The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases in Australia each year and…


58% of Australians say their resolution for 2024 is to eat healthier and more than a quarter (26%) of Australians struggle to make healthy choices at restaurant

Jan 17 2024 - PR NewsWire

93% of Australians are prepared to spend more to order healthier options when eating out yet more than a quarter…


Analyse The Market From A Different Angle